figshare
Browse

Change in activity impairment and work productivity loss from baseline by treatment group over 104 weeks.

Download (939.27 kB)
figure
posted on 2023-11-16, 18:37 authored by Wesley T. Beaulieu, Maureen G. Maguire, Andrew N. Antoszyk
<p>Mean change in activity impairment (A) and work productivity loss (B) by treatment group. Error bars represent 95% confidence intervals.</p>

History

Related Materials

  1. 1.
    DOI - Is supplement to Changes in activity impairment and work productivity after treatment for vitreous hemorrhage due to proliferative diabetic retinopathy: Secondary outcomes from a randomized controlled trial (DRCR Retina Network Protocol AB)

Usage metrics

    PLOS ONE

    Categories

    Keywords

    xlink "> participantsreported outcome measuresrandomized controlled trialrandomized clinical trialproliferative diabetic retinopathyless activity impairmentactivity impairment questionnairework productivity lossvitreous hemorrhage dueadjusted mean differenceactivity impairmentwork productivityvitreous hemorrhageadjusted differencevisual recoverytreated initiallystatistically significantsecondary outcomespanretinal photocoagulationmean reductionmean changemain outcomesdescribe patientaverage rateaflibercept group43 ).39 sites30 %)28 %)25 %)23 %)105 ).104 weeks06 );02 );

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC